Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

White House reviewing drug-pricing plan

Rising drug prices are a top issue for voters. Photo: Education Images / UIG via Getty Images

The White House's Office of Management and Budget is officially evaluating a proposal from the Health and Human Services Department that would "lower drug prices and reduce out-of-pocket costs," ahead of President Trump's speech about drug prices next week.

The big picture: HHS and OMB did not respond when asked what was included, but the proposal likely will include ideas from Trump's budget that won't really target the pricing practices of pharmaceutical manufacturers.

Go deeper

Neal Rothschild, Sara Fischer
1 hour ago - Politics & Policy

The week the Trump show ended

Data: NewsWhip; Chart: Andrew Witherspoon/Axios

Donald Trump was eclipsed in media attention last week by President Biden for the first time since Trump took office, according to viewership data on the internet, on social media and on cable news.

Why it matters: After Trump crowded out nearly every other news figure and topic for five years, momentum of the new administration took hold last week and the former president retreated, partly by choice and partly by being forced off the big platforms.

Go deeper (2 min. read)Arrow
Sara Fischer, author of Media Trends
2 hours ago - Economy & Business

Pay TV's bleak post-pandemic outlook

Data: eMarketer; Chart: Axios Visuals

The pandemic has taken a huge toll on the Pay-TV industry, and with the near-term future of live sports in question, there are no signs of it getting better in 2021.

Why it matters: The fraught Pay-TV landscape is forcing some smaller, niche cable channels out of business altogether.

Go deeper (2 min. read)Arrow
Bethany Allen-Ebrahimian, author of China
2 hours ago - World

Biden sets his sights on China

Photo illustration: Eniola Odetunde/Axios. Photo: Frederic J. Brown/Getty Images  

The new administration's first few moves and statements on China suggest that President Biden may continue some of the Trump era's most assertive policies.

Why it matters: China's severe domestic repression, its dramatic rise as a technological superpower, and its increasingly aggressive actions around the globe mean that the world expects the American president to take action.

Go deeper (3 min. read)Arrow